Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
S Jeon, M Ko, J Lee, I Choi, SY Byun… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Drug repositioning is the only feasible option to immediately address the COVID-19 global
challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory …
challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory …
[HTML][HTML] Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
S Jeon, M Ko, J Lee, I Choi, SY Byun… - Antimicrobial Agents …, 2020 - ncbi.nlm.nih.gov
Drug repositioning is the only feasible option to immediately address the COVID-19 global
challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory …
challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory …
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
S Jeon, M Ko, J Lee, I Choi, SY Byun… - Antimicrobial …, 2020 - pubmed.ncbi.nlm.nih.gov
Drug repositioning is the only feasible option to immediately address the COVID-19 global
challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory …
challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory …
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
S Jeon, M Ko, J Lee, I Choi, SY Byun, S Park… - Antimicrobial Agents …, 2020 - cir.nii.ac.jp
抄録< jats: p> Drug repositioning is the only feasible option to immediately address the
COVID-19 global challenge. We screened a panel of 48 FDA-approved drugs against …
COVID-19 global challenge. We screened a panel of 48 FDA-approved drugs against …
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
S Jeon, M Ko, J Lee, I Choi, SY Byun… - Antimicrobial Agents …, 2020 - europepmc.org
Drug repositioning is the only feasible option to immediately address the COVID-19 global
challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory …
challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory …
Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
S Jeon, M Ko, J Lee, I Choi, SY Byun, S Park, D Shum… - bioRxiv, 2020 - biorxiv.org
COVID-19 is an emerging infectious disease and was recently declared as a pandemic by
WHO. Currently, there is no vaccine or therapeutic available for this disease. Drug …
WHO. Currently, there is no vaccine or therapeutic available for this disease. Drug …
[PDF][PDF] Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
S Jeon, M Ko, J Lee, I Choi, SY Byun, S Park, D Shum… - scholar.archive.org
COVID-19 is an emerging infectious disease and was recently declared as a pandemic by
WHO. Currently, there is no vaccine or therapeutic available for this disease. Drug …
WHO. Currently, there is no vaccine or therapeutic available for this disease. Drug …
Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
S Jeon, M Ko, J Lee, I Choi, SY Byun, S Park, D Shum… - 2020 - pesquisa.bvsalud.org
ABSTRACT COVID-19 is an emerging infectious disease and was recently declared as a
pandemic by WHO. Currently, there is no vaccine or therapeutic available for this disease …
pandemic by WHO. Currently, there is no vaccine or therapeutic available for this disease …
Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs.
S Jeon, M Ko, J Lee, I Choi, SY Byun, S Park, D Shum… - 2020 - cabidigitallibrary.org
Drug repositioning is the only feasible option to immediately address the COVID-19 global
challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory …
challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory …
[PDF][PDF] Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
S Jeon, M Ko, J Lee, I Choi, SY Byun, S Park, D Shum… - biorxiv.org
COVID-19 is an emerging infectious disease and was recently declared as a pandemic by
WHO. Currently, there is no vaccine or therapeutic available for this disease. Drug …
WHO. Currently, there is no vaccine or therapeutic available for this disease. Drug …